Grant: Research Tools and Instruments - Category 1 (<$150,000)
Université de Sherbrooke
$30,562.00
Anaerobic workstation/Station de travail anaérobie
FY 2012-13
Summary
During the past 20 years, bacterial resistance to antibiotics has become a major problem which is recognized by the World Health Organization, the Center for Disease Control and Health Canada. This situation is partly because today's antibiotics are mainly based on a limited selection of chemical scaffolds, which makes it easier for bacterial pathogens to quickly develop resistance against new drug derivatives through mutations or gene transfer. The anaerobic pathogen Clostridium difficile has dramatically increased the hospital-associated deaths in recent years due to the spreading of the high toxin-producing strains, leaving currently little therapeutic solutions. Another anaerobic pathogen Clostridium perfringens causes significant human health problems (gas gangrene) and important economic losses for the Canadian poultry industry. Our laboratories aim at discovering new targets in these two pathogens for the development of drugs that would be devoid of toxicity for human or animal cells. Burrus' laboratory studies the production and degradation of intracellular messenger molecules that are unique to bacteria and are important for the adaptation of microorganisms in response to alteration of the environmental conditions. Malouin's laboratory explores a novel class of antibiotic molecules called ""antibioswitch"" that target the expression of genes important for the synthesis of a key component of the bacterial cell. Sirois's laboratory is developing innovative spectroscopic system for online monitoring of cell physiology that will now be adapted to anaerobic bacteria. Since C. difficile and C. perfringens cannot be cultivated in the presence of oxygen, all experimentation on these two pathogens has to be carried out in a controlled anaerobic atmosphere. The acquisition of the anaerobic workstation that will be shared by our three laboratories will allow us to develop these projects, help us attract quality students interested by emerging anaerobic pathogens and train highly qualified personnel to molecular methods and procedures in anaerobe microbiology.
Program
Research Tools and Instruments - Category 1 (<$150,000)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
439246-2013
Name nom
Burrus, Vincent
Department département
Biologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2013
Award amount
30562
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Anaerobic workstation/Station de travail anaérobie
Keyword
NSERC
Application summary
During the past 20 years, bacterial resistance to antibiotics has become a major problem which is recognized by the World Health Organization, the Center for Disease Control and Health Canada. This situation is partly because today's antibiotics are mainly based on a limited selection of chemical scaffolds, which makes it easier for bacterial pathogens to quickly develop resistance against new drug derivatives through mutations or gene transfer. The anaerobic pathogen Clostridium difficile has dramatically increased the hospital-associated deaths in recent years due to the spreading of the high toxin-producing strains, leaving currently little therapeutic solutions. Another anaerobic pathogen Clostridium perfringens causes significant human health problems (gas gangrene) and important economic losses for the Canadian poultry industry. Our laboratories aim at discovering new targets in these two pathogens for the development of drugs that would be devoid of toxicity for human or animal cells. Burrus' laboratory studies the production and degradation of intracellular messenger molecules that are unique to bacteria and are important for the adaptation of microorganisms in response to alteration of the environmental conditions. Malouin's laboratory explores a novel class of antibiotic molecules called ""antibioswitch"" that target the expression of genes important for the synthesis of a key component of the bacterial cell. Sirois's laboratory is developing innovative spectroscopic system for online monitoring of cell physiology that will now be adapted to anaerobic bacteria. Since C. difficile and C. perfringens cannot be cultivated in the presence of oxygen, all experimentation on these two pathogens has to be carried out in a controlled anaerobic atmosphere. The acquisition of the anaerobic workstation that will be shared by our three laboratories will allow us to develop these projects, help us attract quality students interested by emerging anaerobic pathogens and train highly qualified personnel to molecular methods and procedures in anaerobe microbiology.